Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
BostonGene logo — Transforming Cancer Care: From Treating a Diagnosis to Treat...

BostonGene

Transforming Cancer Care: From Treating a Diagnosis to Treating the Person

Founded 2015 United States Waltham, United States 436 employees Series B Total: $200.00M Analytics, Health Care +1

General Information

Company Name BostonGene
Founded Year 2015
Location United States Waltham, United States +1
Founders / Decision Makers
Team member
Employees 436
Industries Analytics, Health Care, Clean Energy
Funding Stage Series B
Social

Get notified when BostonGene moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BostonGene

BostonGene is a transformative startup with a slogan of "Transforming Cancer Care: From Treating a Diagnosis to Treating the Person." Founded in 2015 and based in the United States, the company is focused on providing AI-integrated molecular analytics and biomarker discovery for precision matching of therapies in cancer and immune-related diseases. BostonGene operates under a concierge-service model, offering customized client solutions utilizing a multi-omic approach prioritized for real-world impact. The startup aims to optimize standard-of-care therapies, accelerate research, and deliver cost-effective, measurable data-driven results. In April 2022, BostonGene secured a significant $150.00M Series B investment from notable investors including Japan Industrial Partners, NEC Corporation, and Impact Investment Capital. The company's tests provide personalized insights into each patient's unique disease profile, offering an in-depth analysis of the immune microenvironment, actionable mutations, biomarkers of response to diverse therapies, and recommended treatment options. BostonGene's comprehensive analyses generate a personalized roadmap for therapeutic decision-making for each patient, aiming to revolutionize cancer care and improve patient outcomes. With its focus on precision medicine and impactful results, the company stands out in the Analytics and Health Care industries, showcasing the potential for successful disruption and innovation in the field of cancer treatment and beyond.

Taxonomy: Precision Medicine, Cancer Care, Biomarker Discovery, AI-Integrated Analytics, Personalized Therapy, Immunooncology, Bioinformatics, Genomics, Medical Technology, Therapeutic Decision-Making, Concierge-Service Model

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 3
Investor
•••• •••• 		06 Apr 2022
Series A •••••• 1 •••• •••• 25 Apr 2019

BostonGene Alternatives & Competitors

BostonGene vs
BIOMAKERS
BIOMAKERS United States

Empowering Therapies with Precision Data

68 employees
Biopharma, Biotechnology
Compare BostonGene vs BIOMAKERS
BostonGene vs
bioSyntagma
bioSyntagma United States

Eliminating trial-and-error cancer treatments through biomarker discovery and predictive analytics

Grant
2 employees
Biotechnology, Life Sciences
Compare BostonGene vs bioSyntagma
BostonGene vs
Xcoo
Xcoo Japan

Genomic Intelligence Based on Advanced Computing, Chrovis

14 employees
Also compare with: BostonGene vs Tailor Bio Tailor Bio

FAQ About BostonGene

Transforming Cancer Care: From Treating a Diagnosis to Treating the Person
BostonGene was founded in 2015.
BostonGene is headquartered in Waltham, United States.
BostonGene operates in the following industries: Analytics, Health Care, Clean Energy.
BostonGene has approximately 436 employees.
BostonGene has completed 2 funding rounds, raising a total of $200.00M. The latest funding stage is Series B.
Top alternatives and competitors to BostonGene include BIOMAKERS, bioSyntagma, Xcoo, Tailor Bio, Akiram Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BostonGene and BIOMAKERS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BostonGene and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy